{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:09:37Z","timestamp":1781629777537,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17ck0106342h0001"],"award-info":[{"award-number":["17ck0106342h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Cancer Research and Development Fund","award":["29-A-14"],"award-info":[{"award-number":["29-A-14"]}]},{"name":"Health, Labor, and Welfare Sciences Research Grants","award":["H30-Gantaisaku-ippan-009"],"award-info":[{"award-number":["H30-Gantaisaku-ippan-009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00277-020-04308-8","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T21:02:11Z","timestamp":1603314131000},"page":"157-165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma\u2014not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry"],"prefix":"10.1007","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5118-7950","authenticated-orcid":false,"given":"Shigeo","family":"Fuji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Kida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitaka","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Miyashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"issue":"25","key":"4308_CR1","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D, International TCLP (2008) International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26(25):4124\u20134130. https:\/\/doi.org\/10.1200\/JCO.2008.16.4558","journal-title":"J Clin Oncol"},{"issue":"11","key":"4308_CR2","doi-asserted-by":"publisher","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","volume":"15","author":"K Ishitsuka","year":"2014","unstructured":"Ishitsuka K, Tamura K (2014) Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol 15(11):e517\u2013e526. https:\/\/doi.org\/10.1016\/S1470-2045(14)70202-5","journal-title":"Lancet Oncol"},{"issue":"4","key":"4308_CR3","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/bjh.12659","volume":"164","author":"D Chihara","year":"2014","unstructured":"Chihara D, Ito H, Matsuda T, Shibata A, Katsumi A, Nakamura S, Tomotaka S, Morton LM, Weisenburger DD, Matsuo K (2014) Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol 164(4):536\u2013545. https:\/\/doi.org\/10.1111\/bjh.12659","journal-title":"Br J Haematol"},{"issue":"10","key":"4308_CR4","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/j.1349-7006.2012.02373.x","volume":"103","author":"D Chihara","year":"2012","unstructured":"Chihara D, Ito H, Katanoda K, Shibata A, Matsuda T, Tajima K, Sobue T, Matsuo K (2012) Increase in incidence of adult T-cell leukemia\/lymphoma in non-endemic areas of Japan and the United States. Cancer Sci 103(10):1857\u20131860. https:\/\/doi.org\/10.1111\/j.1349-7006.2012.02373.x","journal-title":"Cancer Sci"},{"issue":"1","key":"4308_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1158\/1055-9965.Epi-15-0921","volume":"25","author":"N Howlader","year":"2016","unstructured":"Howlader N, Morton LM, Feuer EJ, Besson C, Engels EA (2016) Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends. Cancer Epidemiol Biomarkers Prev 25(1):174\u2013179. https:\/\/doi.org\/10.1158\/1055-9965.Epi-15-0921","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"4308_CR6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3109\/10428194.2010.542596","volume":"52","author":"D Morgensztern","year":"2011","unstructured":"Morgensztern D, Walker GR, Koniaris LG, Lossos IS (2011) Lack of survival improvement in patients with peripheral T-cell lymphoma: a Surveillance, Epidemiology, and End Results analysis. Leuk Lymphoma 52(2):194\u2013204. https:\/\/doi.org\/10.3109\/10428194.2010.542596","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"4308_CR7","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.clml.2015.06.005","volume":"15","author":"JA Crozier","year":"2015","unstructured":"Crozier JA, Sher T, Yang D, Swaika A, Foran J, Ghosh R, Tun H, Colon-Otero G, Kelly K, Chanan-Khan A, Ailawadhi S (2015) Persistent disparities among patients with T-cell non-Hodgkin lymphomas and B-cell diffuse large cell lymphomas over 40 years: a SEER database review. Clin Lymphoma Myeloma Leuk 15(10):578\u2013585. https:\/\/doi.org\/10.1016\/j.clml.2015.06.005","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"5","key":"4308_CR8","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/ijc.29477","volume":"137","author":"D Chihara","year":"2015","unstructured":"Chihara D, Ito H, Izutsu K, Hattori M, Nishino Y, Ioka A, Matsuda T, Ito Y (2015) Advance and stagnation in the treatment of patients with lymphoma and myeloma: analysis using population-based cancer registry data in Japan from 1993 to 2006. Int J Cancer 137(5):1217\u20131223. https:\/\/doi.org\/10.1002\/ijc.29477","journal-title":"Int J Cancer"},{"issue":"3","key":"4308_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3960\/jslrt.17008","volume":"57","author":"H Katsuya","year":"2017","unstructured":"Katsuya H, Ishitsuka K (2017) Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma. J Clin Exp Hematop 57(3):87\u201397. https:\/\/doi.org\/10.3960\/jslrt.17008","journal-title":"J Clin Exp Hematop"},{"issue":"6","key":"4308_CR10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/bjh.14473","volume":"176","author":"N Schmitz","year":"2017","unstructured":"Schmitz N, de Leval L (2017) How I manage peripheral T-cell lymphoma, not otherwise specified and angioimmunoblastic T-cell lymphoma: current practice and a glimpse into the future. Br J Haematol 176(6):851\u2013866. https:\/\/doi.org\/10.1111\/bjh.14473","journal-title":"Br J Haematol"},{"issue":"8","key":"4308_CR11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1200\/JCO.18.00501","volume":"37","author":"LB Cook","year":"2019","unstructured":"Cook LB, Fuji S, Hermine O, Bazarbachi A, Ramos JC, Ratner L, Horwitz S, Fields P, Tanase A, Bumbea H, Cwynarski K, Taylor G, Waldmann TA, Bittencourt A, Marcais A, Suarez F, Sibon D, Phillips A, Lunning M, Farid R, Imaizumi Y, Choi I, Ishida T, Ishitsuka K, Fukushima T, Uchimaru K, Takaori-Kondo A, Tokura Y, Utsunomiya A, Matsuoka M, Tsukasaki K, Watanabe T (2019) Revised adult T-cell leukemia-lymphoma International Consensus Meeting Report. J Clin Oncol 37(8):677\u2013687. https:\/\/doi.org\/10.1200\/JCO.18.00501","journal-title":"J Clin Oncol"},{"issue":"12","key":"4308_CR12","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/bmt.2016.154","volume":"51","author":"EH Phillips","year":"2016","unstructured":"Phillips EH, Hodson A, Hermine O, Bazarbachi A, Cwynarski K (2016) Striving to cure adult T-cell leukaemia\/lymphoma: a role for allogeneic stem cell transplant? Bone Marrow Transplant 51(12):1549\u20131555. https:\/\/doi.org\/10.1038\/bmt.2016.154","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"4308_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1182\/blood-2018-01-791335","volume":"132","author":"N Schmitz","year":"2018","unstructured":"Schmitz N, Lenz G, Stelljes M (2018) Allogeneic hematopoietic stem cell transplantation for T-cell lymphomas. Blood 132(3):245\u2013253. https:\/\/doi.org\/10.1182\/blood-2018-01-791335","journal-title":"Blood"},{"issue":"11","key":"4308_CR14","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.bbmt.2017.07.027","volume":"23","author":"MA Kharfan-Dabaja","year":"2017","unstructured":"Kharfan-Dabaja MA, Kumar A, Ayala E, Hamadani M, Reimer P, Gisselbrecht C, d'Amore F, Jantunen E, Ishida T, Bazarbachi A, Foss F, Advani R, Fenske TS, Lazarus HM, Friedberg JW, Aljurf M, Sokol L, Tobinai K, Tse E, Burns LJ, Chavez JC, Reddy NM, Suzuki R, Ahmed S, Nademanee A, Mohty M, Gopal AK, Fanale MA, Pro B, Moskowitz AJ, Sureda A, Perales MA, Carpenter PA, Savani BN (2017) Clinical practice recommendations on indication and timing of hematopoietic cell transplantation in mature T cell and NK\/T cell lymphomas: an international collaborative effort on behalf of the guidelines committee of the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 23(11):1826\u20131838. https:\/\/doi.org\/10.1016\/j.bbmt.2017.07.027","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"4308_CR15","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.3324\/haematol.2017.164996","volume":"102","author":"S Fuji","year":"2017","unstructured":"Fuji S, Yamaguchi T, Inoue Y, Utsunomiya A, Moriuchi Y, Uchimaru K, Owatari S, Miyagi T, Taguchi J, Choi I, Otsuka E, Nakachi S, Yamamoto H, Kurosawa S, Tobinai K, Fukuda T (2017) Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation. Haematologica 102(7):1258\u20131265. https:\/\/doi.org\/10.3324\/haematol.2017.164996","journal-title":"Haematologica"},{"issue":"7","key":"4308_CR16","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41409-017-0082-4","volume":"53","author":"S Fuji","year":"2018","unstructured":"Fuji S, Kurosawa S, Inamoto Y, Murata T, Utsunomiya A, Uchimaru K, Yamasaki S, Inoue Y, Moriuchi Y, Choi I, Ogata M, Hidaka M, Yamaguchi T, Fukuda T (2018) Role of up-front allogeneic hematopoietic stem cell transplantation for patients with aggressive adult T-cell leukemia-lymphoma: a decision analysis. Bone Marrow Transplant 53(7):905\u2013908. https:\/\/doi.org\/10.1038\/s41409-017-0082-4","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"4308_CR17","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/bmt.2014.143","volume":"49","author":"A Bazarbachi","year":"2014","unstructured":"Bazarbachi A, Cwynarski K, Boumendil A, Finel H, Fields P, Raj K, Nagler A, Mohty M, Sureda A, Dreger P, Hermine O (2014) Outcome of patients with HTLV-1-associated adult T-cell leukemia\/lymphoma after SCT: a retrospective study by the EBMT LWP. Bone Marrow Transplant 49(10):1266\u20131268. https:\/\/doi.org\/10.1038\/bmt.2014.143","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"4308_CR18","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1111\/cas.13343","volume":"108","author":"T Ishida","year":"2017","unstructured":"Ishida T, Utsunomiya A, Jo T, Yamamoto K, Kato K, Yoshida S, Takemoto S, Suzushima H, Kobayashi Y, Imaizumi Y, Yoshimura K, Kawamura K, Takahashi T, Tobinai K, Ueda R (2017) Mogamulizumab for relapsed adult T-cell leukemia-lymphoma: Updated follow-up analysis of phase I and II studies. Cancer Sci 108(10):2022\u20132029. https:\/\/doi.org\/10.1111\/cas.13343","journal-title":"Cancer Sci"},{"issue":"3","key":"4308_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/bjh.15123","volume":"184","author":"T Ishida","year":"2019","unstructured":"Ishida T, Jo T, Takemoto S, Suzushima H, Suehiro Y, Choi I, Yoshimitsu M, Saburi Y, Nosaka K, Utsunomiya A, Kobayashi Y, Yamamoto K, Fujiwara H, Ishitsuka K, Yoshida S, Taira N, Imada K, Kato K, Moriuchi Y, Yoshimura K, Takahashi T, Tobinai K, Ueda R (2019) Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: impact on allogeneic haematopoietic stem cell transplantation. Br J Haematol 184(3):479\u2013483. https:\/\/doi.org\/10.1111\/bjh.15123","journal-title":"Br J Haematol"},{"issue":"5","key":"4308_CR20","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3324\/haematol.2018.205096","volume":"104","author":"AA Phillips","year":"2019","unstructured":"Phillips AA, Fields PA, Hermine O, Ramos JC, Beltran BE, Pereira J, Wandroo F, Feldman T, Taylor GP, Sawas A, Humphrey J, Kurman M, Moriya J, Dwyer K, Leoni M, Conlon K, Cook L, Gonsky J, Horwitz SM, Study G (2019) Mogamulizumab versus investigator's choice of chemotherapy regimen in relapsed\/refractory adult T-cell leukemia\/lymphoma. Haematologica 104(5):993\u20131003. https:\/\/doi.org\/10.3324\/haematol.2018.205096","journal-title":"Haematologica"},{"issue":"3","key":"4308_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2188\/jea.JE20170241","volume":"29","author":"T Morishima","year":"2019","unstructured":"Morishima T, Matsumoto Y, Koeda N, Shimada H, Maruhama T, Matsuki D, Nakata K, Ito Y, Tabuchi T, Miyashiro I (2019) Impact of comorbidities on survival in gastric, colorectal, and lung cancer patients. J Epidemiol 29(3):110\u2013115. https:\/\/doi.org\/10.2188\/jea.JE20170241","journal-title":"J Epidemiol"},{"issue":"3","key":"4308_CR22","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 48(3):452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"4308_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.antiviral.2016.10.015","volume":"137","author":"L Willems","year":"2017","unstructured":"Willems L, Hasegawa H, Accolla R, Bangham C, Bazarbachi A, Bertazzoni U, Carneiro-Proietti AB, Cheng H, Chieco-Bianchi L, Ciminale V, Coelho-Dos-Reis J, Esparza J, Gallo RC, Gessain A, Gotuzzo E, Hall W, Harford J, Hermine O, Jacobson S, Macchi B, Macpherson C, Mahieux R, Matsuoka M, Murphy E, Peloponese JM, Simon V, Tagaya Y, Taylor GP, Watanabe T, Yamano Y (2017) Reducing the global burden of HTLV-1 infection: An agenda for research and action. Antiviral Res 137:41\u201348. https:\/\/doi.org\/10.1016\/j.antiviral.2016.10.015","journal-title":"Antiviral Res"},{"issue":"8","key":"4308_CR24","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","volume":"116","author":"M Hishizawa","year":"2010","unstructured":"Hishizawa M, Kanda J, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, Tanosaki R, Kawano F, Miyazaki Y, Masuda M, Nagafuji K, Hara M, Takanashi M, Kai S, Atsuta Y, Suzuki R, Kawase T, Matsuo K, Nagamura-Inoue T, Kato S, Sakamaki H, Morishima Y, Okamura J, Ichinohe T, Uchiyama T (2010) Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood 116(8):1369\u20131376. https:\/\/doi.org\/10.1182\/blood-2009-10-247510","journal-title":"Blood"},{"key":"4308_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2013.57","volume":"3","author":"D Chihara","year":"2013","unstructured":"Chihara D, Ito H, Matsuda T, Katanoda K, Shibata A, Taniguchi S, Utsunomiya A, Sobue T, Matsuo K (2013) Association between decreasing trend in the mortality of adult T-cell leukemia\/lymphoma and allogeneic hematopoietic stem cell transplants in Japan: analysis of Japanese vital statistics and Japan Society for Hematopoietic Cell Transplantation (JSHCT). Blood Cancer J 3:e159. https:\/\/doi.org\/10.1038\/bcj.2013.57","journal-title":"Blood Cancer J"},{"issue":"1","key":"4308_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/bmt.2010.92","volume":"46","author":"I Choi","year":"2011","unstructured":"Choi I, Tanosaki R, Uike N, Utsunomiya A, Tomonaga M, Harada M, Yamanaka T, Kannagi M, Okamura J, Group Aa-HS (2011) Long-term outcomes after hematopoietic SCT for adult T-cell leukemia\/lymphoma: results of prospective trials. Bone Marrow Transplant 46(1):116\u2013118. https:\/\/doi.org\/10.1038\/bmt.2010.92","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"4308_CR27","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","volume":"30","author":"T Ishida","year":"2012","unstructured":"Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S, Saburi Y, Miyamoto T, Takemoto S, Suzushima H, Tsukasaki K, Nosaka K, Fujiwara H, Ishitsuka K, Inagaki H, Ogura M, Akinaga S, Tomonaga M, Tobinai K, Ueda R (2012) Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol 30(8):837\u2013842. https:\/\/doi.org\/10.1200\/JCO.2011.37.3472","journal-title":"J Clin Oncol"},{"issue":"9","key":"4308_CR28","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1200\/JCO.2009.25.3575","volume":"28","author":"K Yamamoto","year":"2010","unstructured":"Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K, Uike N, Uozumi K, Yamaguchi K, Yamada Y, Hanada S, Tamura K, Nakamura S, Inagaki H, Ohshima K, Kiyoi H, Ishida T, Matsushima K, Akinaga S, Ogura M, Tomonaga M, Ueda R (2010) Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol 28(9):1591\u20131598. https:\/\/doi.org\/10.1200\/JCO.2009.25.3575","journal-title":"J Clin Oncol"},{"issue":"34","key":"4308_CR29","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1200\/JCO.2016.67.7732","volume":"34","author":"T Ishida","year":"2016","unstructured":"Ishida T, Fujiwara H, Nosaka K, Taira N, Abe Y, Imaizumi Y, Moriuchi Y, Jo T, Ishizawa K, Tobinai K, Tsukasaki K, Ito S, Yoshimitsu M, Otsuka M, Ogura M, Midorikawa S, Ruiz W, Ohtsu T (2016) Multicenter phase ii study of lenalidomide in relapsed or recurrent adult T-cell leukemia\/lymphoma: ATLL-002. J Clin Oncol 34(34):4086\u20134093. https:\/\/doi.org\/10.1200\/JCO.2016.67.7732","journal-title":"J Clin Oncol"},{"issue":"5","key":"4308_CR30","doi-asserted-by":"publisher","first-page":"e182","DOI":"10.1016\/S2352-3026(18)30047-4","volume":"5","author":"RA Wilcox","year":"2018","unstructured":"Wilcox RA (2018) Optimising initial treatment for peripheral T-cell lymphoma: a tough nut to CHOP. Lancet Haematol 5(5):e182\u2013e183. https:\/\/doi.org\/10.1016\/S2352-3026(18)30047-4","journal-title":"Lancet Haematol"},{"key":"4308_CR31","unstructured":"Osaka Prefectural Department of Public Health and Welfare, Osaka Medical Association, Osaka International Center Institute: Annual Report of Osaka Cancer Registry No.82 - cancer incidence and medical care in Osaka in 2015 2014 and the survival in 2010 - . (2019). OPDPHW"},{"issue":"11","key":"4308_CR32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2188\/jea.JE20150257","volume":"26","author":"FL Kinoshita","year":"2016","unstructured":"Kinoshita FL, Ito Y, Nakayama T (2016) Trends in Lung Cancer Incidence Rates by Histological Type in 1975-2008: A Population-Based Study in Osaka, Japan. J Epidemiol 26(11):579\u2013586. https:\/\/doi.org\/10.2188\/jea.JE20150257","journal-title":"J Epidemiol"},{"issue":"3","key":"4308_CR33","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/cas.14309","volume":"111","author":"S Okawa","year":"2020","unstructured":"Okawa S, Tabuchi T, Morishima T, Koyama S, Taniyama Y, Miyashiro I (2020) Hospital volume and postoperative 5-year survival for five different cancer sites: a population-based study in Japan. Cancer Sci 111(3):985\u2013993. https:\/\/doi.org\/10.1111\/cas.14309","journal-title":"Cancer Sci"},{"issue":"18","key":"4308_CR34","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1200\/JCO.2016.71.2083","volume":"35","author":"C Laurent","year":"2017","unstructured":"Laurent C, Baron M, Amara N, Haioun C, Dandoit M, Maynadie M, Parrens M, Vergier B, Copie-Bergman C, Fabiani B, Traverse-Glehen A, Brousse N, Copin MC, Tas P, Petrella T, Rousselet MC, Briere J, Charlotte F, Chassagne-Clement C, Rousset T, Xerri L, Moreau A, Martin A, Damotte D, Dartigues P, Soubeyran I, Peoch M, Dechelotte P, Michiels JF, de Mascarel A, Berger F, Bossard C, Arbion F, Quintin-Roue I, Picquenot JM, Patey M, Fabre B, Sevestre H, Le Naoures C, Chenard-Neu MP, Bastien C, Thiebault S, Martin L, Delage M, Filleron T, Salles G, Molina TJ, Delsol G, Brousset P, Gaulard P (2017) Impact of expert pathologic review of lymphoma diagnosis: study of patients from the French lymphopath network. J Clin Oncol 35(18):2008\u20132017. https:\/\/doi.org\/10.1200\/JCO.2016.71.2083","journal-title":"J Clin Oncol"},{"issue":"4","key":"4308_CR35","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/hon.2316","volume":"35","author":"M Bellei","year":"2017","unstructured":"Bellei M, Sabattini E, Pesce EA, Ko YH, Kim WS, Cabrera ME, Martinez V, Dlouhy I, Paes RP, Barrese T, Vassallo J, Tarantino V, Vose J, Weisenburger D, Rudiger T, Federico M, Pileri S (2017) Pitfalls and major issues in the histologic diagnosis of peripheral T-cell lymphomas: results of the central review of 573 cases from the T-Cell Project, an international, cooperative study. Hematol Oncol 35(4):630\u2013636. https:\/\/doi.org\/10.1002\/hon.2316","journal-title":"Hematol Oncol"}],"updated-by":[{"DOI":"10.1007\/s00277-020-04352-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:00:00Z","timestamp":1606521600000}}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04308-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-020-04308-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04308-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T23:24:32Z","timestamp":1634772272000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-020-04308-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["4308"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04308-8","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00277-020-04352-4","asserted-by":"object"}]},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]},"assertion":[{"value":"22 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published: <ExternalRef><RefSource>https:\/\/doi.org\/10.1007\/s00277-020-04308-8<\/RefSource><RefTarget Address=\"10.1007\/s00277-020-04308-8\" TargetType=\"DOI\"\/><\/ExternalRef>","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the institutional review board of the Osaka International Cancer Institute in Osaka, Japan (No. 19088).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}